Companies in #Glaucoma
Found 3 companies operating in this sector.
Ophthalmic pharmaceutical and medical device company developing therapies and surgical devices for glaucoma and corneal disorders.
IRIDEX Corporation is an ophthalmic medical-device company that develops, manufactures and markets laser-based systems, delivery devices and consumable procedure probes for the treatment of glaucoma and retinal diseases. Founded in 1989 and long headquartered in Mountain View, California, the company's intellectual property centers on its proprietary MicroPulse technology, a tissue-sparing, sub-threshold laser approach that delivers laser energy in short pulses with cooling intervals, alongside the Cyclo G6 glaucoma laser platform, the MicroPulse P3 delivery device and the G-Probe family of transscleral probes. The company completed the relocation of its manufacturing operations from Mountain View to San Jose, California in October 2026 as part of a cost-reduction programme.
Ophthalmic medical device company (NASDAQ: SGHT) developing and commercializing surgical and nonsurgical technologies for prevalent eye diseases. Its Surgical Glaucoma segment markets the OMNI family of implant-free minimally invasive glaucoma surgery systems (OMNI Ergo, OMNI EDGE) and the SION bladeless excisional device; its Dry Eye segment markets the TearCare interventional dry eye system for evaporative dry eye disease. Q2 2026 revenue grew roughly 20% year over year, prompting the company to raise full-year 2026 revenue guidance and lower adjusted operating expense guidance, and the stock gained about 28% in a single August 2026 session.